header-image

Jerry (J) Janssen PhD

Training

BSc Biomedical Sciences, MSc Oncology, PhD

Research interests

  • B-cell Immunology
  • hemato-oncology
  • antigen-specific B-cell responses

Technology

  • FACS
  • ELISA
  • Cell-based assays
  • Immunohistochemistry

Resume

2020-present

Postdoctoral fellow at Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands

2015-2019

PhD candidate at Department of Pathology, Amsterdam UMC, Amsterdam Medical Center, The Netherlands

2010-2012

MSc Oncology, VU University of Amterdam, The Netherlands

2006-2010

BSc Biomedical Sciences, VU University of Amsterdam, The Netherlands

Other publications

  • Bende RJ, Janssen J, Beentjes A, Wormhoudt TAM, Wagner K, Haacke EA, et al. Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjogren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG. Arthritis Rheumatol. 2020
  • Dyczynski M, Vesterlund M, Bjorklund AC, Zachariadis V, Janssen J, Gallart-Ayala H, et al. Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment.  Cell Death Dis. 2018;9(9):846
  • Bende RJ, Janssen J, Wormhoudt TA, Wagner K, Guikema JE, van Noesel CJ. Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity. Haematologica. 2016;101(5):e200-3
  • Voorham QJ, Janssen J, Tijssen M, Snellenberg S, Mongera S, van Grieken NC, et al. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas. BMC Cancer. 2013;13:603